Filing Flows

Filing Flows › Companies › VivoSim Labs › Cash flow

VivoSim Labs cash flow, quarter by quarter

Latest: Q1 FY27 · from the cash-flow statements filed with the SEC

Free cash flow−$3.2M in Q1 FY27 · −$10.1M over twelve months

Operating cash flow−$3.2M
Capital spending−$23K
Free cash flow−$3.2M

Analysis

In Q1 FY27, VivoSim Labs generated −$3.2M of operating cash flow and spent $23K on capital projects, leaving free cash flow of −$3.2M. That is $704K more than in Q1 FY26 (−$3.9M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$10.1M; the largest uses were operating cash flow ($10.1M), other financing ($353K), capital spending ($23K); besides operations, cash came from shares issued ($3.0M), other investing ($94K); the cash balance fell by $7.4M.

Operating cash flow was −$3.2M against net income of −$1.3M. The largest differences: payables −$400K, accrued liabilities −$243K, stock-based pay +$91K.

Free cash flow

VivoSim Labs: free cash flow by quarterVivoSim Labs: free cash flow by quarter−$2.7MQ2 FY25−$1.8MQ3 FY25−$2.0MQ4 FY25−$3.9MQ1 FY26−$2.4MQ2 FY26−$2.3MQ3 FY26−$2.2MQ4 FY26−$3.2MQ1 FY27
Operating cash flow less capital spending.
VivoSim Labs: operating cash flow against capital spendingVivoSim Labs: operating cash flow against capital spendingOperating cash flowCapital spending−$2.6M$13KQ2 FY25−$1.8M$0Q3 FY25−$2.0M$0Q4 FY25−$3.9M$0Q1 FY26−$2.4M$0Q2 FY26−$2.3M$0Q3 FY26−$2.2M$0Q4 FY26−$3.2M$23KQ1 FY27
Latest (Q1 FY27): Operating cash flow −$3.2M, Capital spending $23K.

Capital allocation, year by year

VivoSim Labs: where the cash came from (up) and went (down), by fiscal yearVivoSim Labs: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedCapital spendingFY22: Operating cash flow −$8.5MFY22: Shares issued $251KFY22: Capital spending −$409K$251KFY22FY23: Operating cash flow −$12.4MFY23: Capital spending −$396KFY23FY24: Operating cash flow −$14.7MFY24: Shares issued $1.4MFY24: Capital spending −$42K$1.4MFY24FY25: Operating cash flow −$9.5MFY25: Shares issued $8.8MFY25: Capital spending −$13K$8.8MFY25FY26: Operating cash flow −$10.8MFY26: Shares issued $4.8M$4.8MFY26
Over these 5 years operating cash flow totalled −$55.8M; the largest uses were operating cash flow ($55.8M) and capital spending ($860K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.7M
Debtnone
Net cash$1.7M
Cash runway2 months

VivoSim Labs is burning cash: its operations consume cash, a free cash flow of −$10.1M a year at the current rate against $1.7M of cash and investments: a runway of about 2 months before any new financing.

Where the cash came from and went

VivoSim Labs: sources (+) and uses (−) of cash, Q1 FY27VivoSim Labs: sources (+) and uses (−) of cash, Q1 FY27Cash drawn (+) / kept (−)$3.4MOperating cash flow−$3.2MOther financing−$118KCapital spending−$23K
VivoSim Labs: sources (+) and uses (−) of cash, TTM to Q1 FY27VivoSim Labs: sources (+) and uses (−) of cash, TTM to Q1 FY27Operating cash flow−$10.1MCash drawn (+) / kept (−)$7.4MShares issued$3.0MOther financing−$353KOther investing$94KCapital spending−$23K

From profit to cash

VivoSim Labs: net income to operating cash flow, Q1 FY27VivoSim Labs: net income to operating cash flow, Q1 FY27Net income−$1.3MDepreciation & amortization$40KStock-based pay$91KReceivables$3KPayables−$400KAccrued liabilities−$243KPrepaid and other assets$47KOperating cash flow−$3.2M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 FY251051472031027-16202
Q2 FY251184820870748-22422

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q1 FY27−$3.2M−$23K—$3.4M−$3.2M
Q4 FY26−$2.2M—$3.0M−$736K−$2.2M
Q3 FY26−$2.3M——$2.4M−$2.3M
Q2 FY26−$2.4M——$2.4M−$2.4M
Q1 FY26−$3.9M—$1.8M$2.3M−$3.9M
Q4 FY25−$2.0M—$3.2M−$10.2M−$2.0M
Q3 FY25−$1.8M—−$216K$2.0M−$1.8M
Q2 FY25−$2.6M−$13K−$371K$3.0M−$2.7M

VivoSim Labs: income statement and cash flow

VivoSim Labs, Q1 FY27: revenue $18K (-51% year over year). The chart follows the revenue to costs, profit and cash.

VivoSim Labs: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.